Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Open in Screener

ILMN

Illumina Inc

May 17 • 04:00PM ET

111.07

Dollar change -3.39
Percentage change -2.96	%

Healthcare • Diagnostics & Research • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO VO QQQ VUG IVV VOT IBB RSP VHT

Index	NDX, S&P 500	P/E	-	EPS (ttm)	-8.15	Insider Own	0.54%	Shs Outstand	159.00M	Perf Week	0.49%
Market Cap	17.69B	Forward P/E	45.74	EPS next Y	2.43	Insider Trans	0.86%	Shs Float	158.44M	Perf Month	-4.82%
Income	-1290.00M	PEG	-	EPS next Q	0.09	Inst Own	91.83%	Short Float	3.00%	Perf Quarter	-22.55%
Sales	4.49B	P/S	3.94	EPS this Y	-16.08%	Inst Trans	2.72%	Short Ratio	2.98	Perf Half Y	10.88%
Book/sh	36.06	P/B	3.08	EPS next Y	236.43%	ROA	-11.81%	Short Interest	4.76M	Perf Year	-43.76%
Cash/sh	7.00	P/C	15.87	EPS next 5Y	23.95%	ROE	-20.76%	52W Range	89.00 - 213.91	Perf YTD	-20.23%
Dividend Est.	-	P/FCF	48.48	EPS past 5Y	-	ROI	-16.28%	52W High	-48.08%	Beta	1.22
Dividend TTM	-	Quick Ratio	1.36	Sales past 5Y	7.40%	Gross Margin	61.38%	52W Low	24.80%	ATR (14)	4.54
Dividend Ex-Date	-	Current Ratio	1.75	EPS Y/Y TTM	71.48%	Oper. Margin	-1.51%	RSI (14)	36.25	Volatility	3.38% 3.62%
Employees	12010	Debt/Eq	0.40	Sales Y/Y TTM	1.03%	Profit Margin	-28.71%	Recom	2.42	Target Price	149.53
Option/Short	Yes / Yes	LT Debt/Eq	0.38	EPS Q/Q	-4270.53%	Payout	-	Rel Volume	0.65	Prev Close	114.46
Sales Surprise	2.44%	EPS Surprise	109.79%	Sales Q/Q	-1.01%	Earnings	May 02 AMC	Avg Volume	1.60M	Price	111.07
SMA20	-6.07%	SMA50	-11.58%	SMA200	-16.88%	Trades		Volume	1,035,663	Change	-2.96%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-16-24	Downgrade	HSBC Securities	Buy → Hold
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$144
Dec-18-23	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$185
Dec-15-23	Upgrade	Bernstein	Underperform → Mkt Perform
Dec-14-23	Initiated	Stephens	Overweight	$170
Dec-14-23	Initiated	Guggenheim	Buy	$155
Dec-13-23	Initiated	Wolfe Research	Outperform	$175
Dec-12-23	Downgrade	BofA Securities	Neutral → Underperform	$140 → $100
Dec-11-23	Upgrade	Citigroup	Sell → Neutral	$85 → $120
Nov-10-23	Downgrade	Canaccord Genuity	Buy → Hold	$210 → $120
Sep-28-23	Initiated	Bernstein	Underperform	$111
Jul-05-23	Resumed	JP Morgan	Neutral	$235
Jan-25-23	Downgrade	Argus	Buy → Hold
Jan-05-23	Initiated	Scotiabank	Sector Perform	$216
Dec-12-22	Downgrade	Citigroup	Neutral → Sell	$200 → $180
Dec-07-22	Initiated	RBC Capital Mkts	Outperform	$282
Oct-04-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$220 → $270
Sep-28-22	Upgrade	Evercore ISI	In-line → Outperform	$170 → $250
Aug-25-22	Initiated	Credit Suisse	Neutral	$230
Jul-13-22	Downgrade	Barclays	Equal Weight → Underweight	$350 → $150

Show Previous Ratings

May-15-24 04:05PM	Illumina To Webcast Upcoming Investor Conference (PR Newswire)
05:58AM	Daiwa Securities Adjusts Price Target on Illumina to $120 From $133 (MT Newswires)
May-13-24 12:22PM	SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:45AM	Standard BioTools Inc. (NASDAQ:LAB) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 06:00AM	Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life (InvestorPlace)
07:15AM	Loading…
May-07-24 07:15AM	Illumina Files Registration Statement for Planned GRAIL Divestiture (MT Newswires) -5.18%
May-06-24 06:28PM	Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL (PR Newswire)
May-03-24 11:55AM	Illumina, Inc. (NASDAQ:ILMN) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:46AM	Bernstein Adjusts Illumina's Price Target to $130 From $129 (MT Newswires)
10:46AM	TD Cowen Adjusts Illumina's Price Target to $140 From $150 (MT Newswires)
10:20AM	Baird Raises Price Target on Illumina to $128 From $125 (MT Newswires)
09:39AM	Illumina (ILMN) Q1 Earnings Beat, Adjusted Operating Loss Widens (Zacks)
09:25AM	Illumina To Webcast Upcoming Investor Conference (PR Newswire)
09:18AM	Evercore ISI Adjusts Price Target on Illumina to $195 From $200 (MT Newswires)
07:16AM	Q1 2024 Illumina Inc Earnings Call (Thomson Reuters StreetEvents)
06:55AM	Loading…
06:55AM	Leerink Adjusts Price Target on Illumina to $150 From $155 (MT Newswires)
04:12AM	Illumina Inc (ILMN) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com)
May-02-24 09:46PM	Analyst Report: Illumina, Inc. (Morningstar Research)
08:56PM	ILMN Stock Earnings: Illumina Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
07:30PM	Illumina (ILMN) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
06:25PM	Illumina reaffirms annual revenue forecast over continued sluggish demand (Reuters)
05:35PM	Illumina Inc (ILMN) Q1 Earnings: Navigating Through Challenges with Mixed Results (GuruFocus.com)
05:21PM	Illumina Q1 Non-GAAP Earnings Increase, Revenue Decreases -- Shares Down After Hours (MT Newswires)
04:17PM	Illumina: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Illumina Reports Financial Results for First Quarter of Fiscal Year 2024 (PR Newswire)
06:04AM	3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire (InvestorPlace)
Apr-29-24 09:09PM	Lightning Round: Illumina is a good company that's poorly run, says Jim Cramer (CNBC TV)
12:45PM	Inspiring Young Minds: HRH the Princess Royal Helps Illumina Celebrate DNA Day (ACCESSWIRE)
09:16AM	Gear Up for Illumina (ILMN) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Apr-26-24 06:03AM	Shein to face tougher online content rules as EU designates it as very large online platform (Reuters)
10:02AM	Loading…
Apr-25-24 10:02AM	Illumina (ILMN) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
08:53AM	20 Countries with the Highest Rates of Stomach Cancer in the World (Insider Monkey)
Apr-21-24 08:30AM	This CEO has battled billionaire activist Carl Icahn twice here's his advice to Disney CEO Bob Iger (Yahoo Finance)
Apr-19-24 02:05PM	20 Countries with the Highest Cancer Survival Rates in the World (Insider Monkey)
12:10PM	Can Illumina (ILMN) Keep the Earnings Surprise Streak Alive? (Zacks)
Apr-18-24 01:30PM	Engineering a Cool Career in Biotech - and Volunteering Along the Way (ACCESSWIRE)
08:00AM	QQQ Has Some Inexpensive Growth Stocks (ETF Trends)
Apr-17-24 09:30AM	Evidence Supports Sequencing As First-Line Rare Disease Diagnostic (ACCESSWIRE)
Apr-15-24 05:40AM	European Commission approves Illuminas proposed Grail split (MedTech Dive)
Apr-12-24 09:00AM	Illumina's planned divestment of GRAIL approved by the European Commission (PR Newswire)
06:21AM	UPDATE 2-EU approves Illumina's plan to divest cancer test maker Grail (Reuters)
05:49AM	EU approves Illumina's plan to divest cancer test maker Grail (Reuters)
Apr-10-24 08:16AM	Search for Cancer Blood Test Continues Despite Illumina-Grail Deals Failure (Barrons.com)
Apr-09-24 11:37PM	Illumina CFO steps down amid executive shakeup (MedTech Dive)
05:28PM	UPDATE 2-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed (Reuters)
04:32PM	Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed (Reuters)
04:28PM	CORRECTED-UPDATE 1-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed (Reuters)
04:18PM	CORRECTED-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra named successor (Reuters)
04:05PM	Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer (PR Newswire)
Apr-05-24 02:27PM	Nasdaqs Nosebleed Section: 3 Expensive Stocks to Sell Before Its Too Late (InvestorPlace)
12:45PM	Why More Clinical Labs Are Turning to Whole-Genome Sequencing for Cancer (ACCESSWIRE)
Apr-04-24 05:00PM	Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024 (PR Newswire)
Apr-02-24 09:45AM	Giving Students a New Window on Genomic Technologies (ACCESSWIRE)
Mar-30-24 07:43PM	20 Foods To Reduce Cancer Risk (Insider Monkey)
Mar-26-24 08:02AM	14 Best Medical Device Stocks To Buy Now (Insider Monkey)
Mar-25-24 06:17AM	Court adviser sides with Illumina in EU row that triggered Grail fine (MedTech Dive)
Mar-21-24 06:37PM	Why Illumina Stock Zoomed Higher on Thursday (Motley Fool)
05:44AM	UPDATE 2-EU merger powers may be curbed after court adviser backs Illumina fight (Reuters)
05:12AM	EU merger powers may be curbed after court adviser backs Illumina fight (Reuters)
05:01AM	EU court should back Illumina's appeal against EU review of Grail deal, court adviser says (Reuters)
Mar-18-24 12:40PM	A Biobank for the Americas and a Genomics Lab Power Precision Health for All (ACCESSWIRE)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-14-24 07:42PM	Analyst Report: Illumina, Inc. (Morningstar Research)
Mar-13-24 06:43AM	10 Biggest Stocks Targeted By Activist Investors Right Now (Insider Monkey)
Mar-12-24 04:50PM	S&P 500 Gains and Losses Today: Oracle Surges as Results Show AI Advancement (Investopedia)
02:41PM	Carl Icahn Drops Plans for New Proxy Fight at Illumina (Bloomberg)
01:57PM	Exclusive-Icahn drops Illumina board challenge threat, sources say (Reuters)
Mar-08-24 08:45AM	Finding the Needle in the Genomic Haystack With DRAGEN (ACCESSWIRE)
Mar-07-24 03:00PM	3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise (InvestorPlace)
08:45AM	Video: Give Someone a Fish, You Feed Them - Unlock the Fish Genome, You Feed the World (ACCESSWIRE)
Mar-02-24 02:30PM	FTC's suit against Kroger-Albertsons merger will have a 'chilling effect' on M&A activity (Yahoo Finance)
Feb-28-24 05:52AM	Reasons for the Decline of Illumina (ILMN) (Insider Monkey)
Feb-27-24 03:40AM	Do You Believe in the Growth Prospects of Illumina (ILMN)? (Insider Monkey)
03:09AM	Jenny Zheng joins Illumina as Senior Vice President and General Manager of Greater China (PR Newswire)
Feb-26-24 06:29PM	Why Illumina Stock Mashed the Market on Monday (Motley Fool)
11:00AM	Illumina Inc CEO Jacob Thaysen Acquires 7,330 Shares (GuruFocus.com)
Feb-24-24 06:50AM	15 Best Shareholder Activism Law Firms (Insider Monkey)
Feb-23-24 07:59AM	Activist Investor Alert: The Top 3 Stocks Carl Icahn Is Targeting in 2024 (InvestorPlace)
Feb-21-24 07:42PM	Analyst Report: Illumina, Inc. (Morningstar Research)
09:00AM	Icahn Enterprises L.P. Announces Management & Financial Update (PR Newswire)
Feb-20-24 10:25AM	Illumina (ILMN) Rides on NGS Portfolio Expansion Amid Macro Woe (Zacks)
Feb-14-24 07:00PM	Illumina, already facing pressure from Icahn, saw other activists at year end (Reuters) +5.23%
09:40AM	Illumina Named One of Americas Most JUST Companies and Included in the 2024 S&P Global Sustainability Yearbook (ACCESSWIRE)
Feb-09-24 11:19AM	Illumina, Inc. (NASDAQ:ILMN) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:52AM	Q4 2023 Illumina Inc Earnings Call (Thomson Reuters StreetEvents)
07:39AM	Illumina (ILMN) Q4 Earnings Surpass Estimates, Margin Down (Zacks)
05:45AM	Illumina cut 12% of global staff over past year: CEO (MedTech Dive)
01:32AM	Analyst Report: Illumina, Inc. (Morningstar Research)
Feb-08-24 06:30PM	Illumina (ILMN) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:24PM	Illumina forecasts flat 2024 sales as sluggish demand drags on (Reuters)
04:34PM	Illumina Inc (ILMN) Reports Mixed Fiscal Year 2023 Results Amidst GRAIL Divestiture (GuruFocus.com)
04:24PM	Illumina: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2023 (PR Newswire)
09:14AM	Illumina to lay off 111 people at San Diego headquarters (MedTech Dive)
Feb-05-24 09:16AM	Seeking Clues to Illumina (ILMN) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
Feb-01-24 09:10PM	Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements (InvestorPlace)
Jan-30-24 07:31AM	Illumina (ILMN) Leads the Market With 80% Share (Insider Monkey)
Jan-29-24 07:49PM	Analyst Report: Illumina, Inc. (Morningstar Research)
Jan-28-24 09:25AM	3 Stocks to Buy for the Age of Personalized Medicine (InvestorPlace)
Jan-23-24 08:45PM	Cramer's Lightning Round: Fluor, Illumina and Ferrari (CNBC TV)

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Thaysen Jacob	Chief Executive Officer	Feb 22 '24	Buy	135.29	7,330	991,672	14,861	Feb 26 08:57 AM
Hoyt Aimee L	SVP, Chief People Officer	Nov 07 '23	Sale	112.84	315	35,545	8,314	Nov 09 04:22 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Aug 22 '23	Sale	167.04	500	83,520	45,524	Aug 24 04:19 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Jul 24 '23	Sale	190.08	500	95,040	46,022	Jul 26 06:14 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Jun 22 '23	Sale	200.00	500	100,000	46,522	Jun 26 05:23 PM
EPSTEIN ROBERT S	Director	May 25 '23	Option Exercise	71.09	7,600	540,284	14,764	May 25 04:34 PM

Open in Screener

EW

Edwards Lifesciences Corp

May 17 • 04:00PM ET

89.14

Dollar change -0.97
Percentage change -1.08	%

Healthcare • Medical Devices • USA • NYSE

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO IVV VUG IHI IWF VHT QUAL RSP SCHG

Index	S&P 500	P/E	38.31	EPS (ttm)	2.33	Insider Own	1.61%	Shs Outstand	601.10M	Perf Week	2.79%
Market Cap	53.72B	Forward P/E	28.63	EPS next Y	3.11	Insider Trans	-4.18%	Shs Float	592.90M	Perf Month	3.11%
Income	1.41B	PEG	4.06	EPS next Q	0.69	Inst Own	83.76%	Short Float	1.62%	Perf Quarter	3.53%
Sales	6.14B	P/S	8.74	EPS this Y	10.43%	Inst Trans	-0.08%	Short Ratio	2.88	Perf Half Y	33.02%
Book/sh	11.82	P/B	7.54	EPS next Y	12.34%	ROA	15.38%	Short Interest	9.63M	Perf Year	1.69%
Cash/sh	2.82	P/C	31.58	EPS next 5Y	9.44%	ROE	21.59%	52W Range	60.57 - 96.12	Perf YTD	16.90%
Dividend Est.	-	P/FCF	197.92	EPS past 5Y	15.35%	ROI	18.14%	52W High	-7.26%	Beta	1.12
Dividend TTM	-	Quick Ratio	2.67	Sales past 5Y	10.28%	Gross Margin	76.11%	52W Low	47.17%	ATR (14)	2.03
Dividend Ex-Date	-	Current Ratio	3.75	EPS Y/Y TTM	-3.43%	Oper. Margin	27.71%	RSI (14)	54.73	Volatility	2.38% 2.22%
Employees	19800	Debt/Eq	0.10	Sales Y/Y TTM	11.68%	Profit Margin	23.01%	Recom	2.03	Target Price	96.55
Option/Short	Yes / Yes	LT Debt/Eq	0.09	EPS Q/Q	4.50%	Payout	0.00%	Rel Volume	0.62	Prev Close	90.11
Sales Surprise	1.80%	EPS Surprise	2.66%	Sales Q/Q	9.50%	Earnings	Apr 25 AMC	Avg Volume	3.34M	Price	89.14
SMA20	3.02%	SMA50	-0.95%	SMA200	13.67%	Trades		Volume	2,063,356	Change	-1.08%

Date	Action	Analyst	Rating Change	Price Target Change
May-14-24	Upgrade	Deutsche Bank	Hold → Buy
Mar-07-24	Upgrade	BofA Securities	Neutral → Buy
Feb-02-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$94
Jan-04-24	Downgrade	Evercore ISI	Outperform → In-line	$80 → $77
Dec-11-23	Downgrade	Citigroup	Buy → Neutral
Nov-28-23	Downgrade	Wolfe Research	Peer Perform → Underperform	$57
Sep-26-23	Upgrade	Oppenheimer	Perform → Outperform	$90
Jul-19-23	Initiated	Robert W. Baird	Outperform	$107
May-30-23	Resumed	Morgan Stanley	Overweight	$102
Mar-29-23	Initiated	UBS	Neutral	$84
Mar-08-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$97 → $78
Feb-06-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-31-23	Downgrade	Bernstein	Outperform → Underperform	$95 → $66
Jan-30-23	Downgrade	Piper Sandler	Overweight → Neutral	$95 → $80
Dec-06-22	Downgrade	Stifel	Buy → Hold	$95 → $75
Oct-28-22	Downgrade	Oppenheimer	Outperform → Perform
Oct-26-22	Initiated	Mizuho	Buy	$100
Oct-18-22	Initiated	Barclays	Overweight	$96
Oct-12-22	Initiated	Jefferies	Buy	$110
Jul-29-22	Downgrade	Canaccord Genuity	Buy → Hold	$115 → $106

Show Previous Ratings

May-14-24 04:33PM	Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint (Benzinga)
07:53AM	Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86 (MT Newswires)
May-13-24 05:52PM	Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing (MT Newswires)
02:20PM	Market Chatter: Edwards Lifesciences Faces EU Antitrust Complaint By Meril (MT Newswires)
May-08-24 07:21PM	Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability (Business Wire)
07:52AM	Loading…
May-07-24 07:52AM	Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100 (MT Newswires)
May-01-24 05:27PM	Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing (MT Newswires)
09:40AM	Is Edwards Lifesciences (EW) Outperforming Other Medical Stocks This Year? (Zacks)
09:35AM	Down -10.22% in 4 Weeks, Here's Why You Should You Buy the Dip in Edwards Lifesciences (EW) (Zacks)
Apr-30-24 05:03PM	Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing (MT Newswires)
10:20AM	Edwards Lifesciences Corporation (NYSE:EW) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-29-24 02:22PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
12:18PM	Investing in Edwards Lifesciences (EW)? Don't Miss Assessing Its International Revenue Trends (Zacks)
07:23AM	Bernstein Adjusts Price Target on Edwards Lifesciences to $73 From $72 (MT Newswires)
Apr-26-24 04:09PM	This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss (Investor's Business Daily)
11:21AM	Loading…
11:21AM	Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92 (MT Newswires)
11:09AM	Edwards Lifesciences (EW) Q1 Earnings Top, 2024 Sales View Up (Zacks)
10:54AM	Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $83 (MT Newswires)
10:42AM	UBS Adjusts Edwards Lifesciences Price Target to $95 From $92, Maintains Neutral Rating (MT Newswires)
10:38AM	Q1 2024 Edwards Lifesciences Corp Earnings Call (Thomson Reuters StreetEvents)
10:29AM	Piper Sandler Adjusts Price Target on Edwards Lifesciences to $88 From $85 (MT Newswires)
09:53AM	Canaccord Genuity Trims Price Target on Edwards Lifesciences to $85 From $86 (MT Newswires)
08:28AM	Edwards gets Q1 boost as Pascal valve repair sales ramp up (MedTech Dive)
03:40AM	Edwards Lifesciences Corp (EW) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ... (GuruFocus.com)
Apr-25-24 06:00PM	Compared to Estimates, Edwards Lifesciences (EW) Q1 Earnings: A Look at Key Metrics (Zacks)
05:52PM	Edwards Lifesciences Q1 Earnings: Mixed Results with Adjusted EPS Beating Estimates (GuruFocus.com)
05:30PM	Edwards Lifesciences (EW) Q1 Earnings and Revenues Top Estimates (Zacks)
05:04PM	Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff (Investor's Business Daily)
04:34PM	Edwards Lifesciences Q1 Adjusted Earnings, Net Sales Increase, Q2 Guidance Set (MT Newswires)
04:26PM	Edwards Lifesciences: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Loading…
04:15PM	Edwards Lifesciences Reports First Quarter Results (Business Wire)
Apr-23-24 06:14AM	Boston Scientific, Dexcom and Edwards next as earnings season rolls on (MedTech Dive)
Apr-22-24 09:16AM	Unveiling Edwards Lifesciences (EW) Q1 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Apr-19-24 01:08AM	Spinoffs, sales and tuck-ins top medtech deal priorities: Moodys (MedTech Dive)
Apr-18-24 10:01AM	Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
07:10AM	Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024 (Business Wire)
Apr-17-24 11:01AM	Is a Beat Likely for Edwards Lifesciences (EW) in Q1 Earnings? (Zacks)
Apr-12-24 04:37AM	Abbotts Nadim Geloo on Triclips US launch, Edwards competition (MedTech Dive)
Apr-07-24 04:30PM	Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It (Business Wire)
Mar-26-24 08:02AM	14 Best Medical Device Stocks To Buy Now (Insider Monkey)
Mar-25-24 09:40AM	Are Medical Stocks Lagging Edwards Lifesciences (EW) This Year? (Zacks)
Mar-19-24 02:24PM	Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark (Investor's Business Daily)
01:38PM	Edwards Lifesciences (EW) Up 21.8% YTD: What's Driving It? (Zacks)
Mar-15-24 04:02PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
10:50AM	Edwards Lifesciences (EW) Hits 52-Week High: What's Driving It? (Zacks)
Mar-13-24 11:57AM	Edwards Lifesciences' (EW) SAPIEN TAVR Study Outcome Favorable (Zacks)
Mar-11-24 02:00PM	Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR (Business Wire)
Mar-07-24 04:57PM	S&P 500 Gains and Losses Today: Index Notches Record Close Ahead of Jobs Report (Investopedia) +6.20%
11:31AM	Edwards Lifesciences (EW) Up 2% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-06-24 09:43AM	Edwards (EW) Gains From RESILIA's Global Adoption, TAVR Growth (Zacks)
Feb-26-24 11:54AM	Here's Why You Should Buy Edward Lifesciences (EW) Stock Now (Zacks)
Feb-23-24 07:05AM	Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference (Business Wire)
Feb-18-24 01:26PM	25 Most Valuable Medical Device Companies in the US (Insider Monkey)
Feb-15-24 09:36AM	Edwards (EW) Gains From Balanced Core Growth and New Launches (Zacks)
Feb-13-24 12:09AM	Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insight (GuruFocus.com)
Feb-09-24 02:21AM	Edwards Lifesciences Corp Director Heisz Stone Sells 7,056 Shares (GuruFocus.com)
Feb-07-24 04:11PM	Edwards Lifesciences' Fortunes Are Reaccelerating, Analyst Says But Its Stock Isn't (Investor's Business Daily)
11:19AM	Edwards Lifesciences Corporation (NYSE:EW) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:31AM	Edwards Lifesciences (EW) Q4 Earnings Meet, Margins Dip (Zacks)
09:06AM	Q4 2023 Edwards Lifesciences Corp Earnings Call (Thomson Reuters StreetEvents)
05:54AM	How Edwards Evoque valve won an early nod from the FDA (MedTech Dive)
Feb-06-24 07:55PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
06:00PM	Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics (Zacks)
05:25PM	Edwards Lifesciences (EW) Q4 Earnings Match Estimates (Zacks)
04:54PM	Edwards Lifesciences Corp (EW) Reports Robust Q4 and Full-Year 2023 Financial Results (GuruFocus.com)
04:44PM	Edwards Lifesciences Dips On In-Line Profit, Narrow Sales Beat (Investor's Business Daily)
04:40PM	Edwards Lifesciences: Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	Edwards Lifesciences Reports Fourth Quarter Results (Business Wire)
07:18AM	Edwards Lifesciences (EW) Wins FDA Nod for the EVOQUE System (Zacks)
Feb-02-24 07:00AM	Edwards EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve (Business Wire) +9.38%
06:27AM	Edwards receives FDA approval for first transcatheter tricuspid valve replacement treatment (MedTech Dive)
Feb-01-24 09:15AM	Stay Ahead of the Game With Edwards Lifesciences (EW) Q4 Earnings: Wall Street's Insights on Key Metrics (Zacks)
07:44AM	Strength Seen in Edwards Lifesciences (EW): Can Its 6.2% Jump Turn into More Strength? (Zacks)
Jan-30-24 07:05AM	Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024 (Business Wire)
06:15AM	4 heart device trends shaping the medtech sector in 2024 (MedTech Dive)
Jan-23-24 07:07AM	Edwards risks TAVR market share slip amid challenges from Abbott, Boston Scientific: survey (MedTech Dive)
Jan-19-24 11:26AM	What's in Store for Edwards Lifesciences (EW) in Q4 Earnings? (Zacks)
Jan-16-24 01:20AM	Edwards Lifesciences Corporation (EW) Fell in Q4 Despite Double-Digit Revenue Growth (Insider Monkey)
Jan-03-24 07:40AM	Here's Why You Should Retain Edward Lifesciences (EW) Stock Now (Zacks)
Jan-02-24 09:00AM	Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-20-23 05:24AM	Fears Of Negative Clinical Trial Result Dragged Edwards Lifesciences Corporation (EW) in Q3 (Insider Monkey)
Dec-14-23 07:49PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
Dec-11-23 12:27PM	Edwards Lifesciences (EW) Forwards Growth Strategy and Outlook (Zacks)
Dec-08-23 05:11AM	Edwards to spin off its critical care business (MedTech Dive)
Dec-07-23 05:00PM	S&P 500 Gains and Losses Today: AI Excitement Powers AMD, Alphabet (Investopedia)
08:30AM	Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference (Business Wire)
Nov-26-23 05:56AM	12 Best Medical Technology Stocks To Buy Now (Insider Monkey)
Nov-25-23 06:58AM	Could Ozempic Harm These 3 Medical Device Stocks? (Motley Fool)
Nov-24-23 11:31AM	Edwards Lifesciences (EW) Up 6.8% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-23-23 06:06AM	Here's Why You Should Retain Edward Lifesciences (EW) Stock Now (Zacks)
Oct-30-23 11:40AM	ITGR or EW: Which Is the Better Value Stock Right Now? (Zacks)
Oct-27-23 07:30AM	DexCom (DXCM) Beats on Q3 Earnings, Raises Sales Outlook (Zacks)
Oct-26-23 06:15PM	Why Edwards Lifesciences Stock Plummeted Today (Motley Fool) -8.14%
03:06PM	CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION (PR Newswire)
02:00PM	TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION (PR Newswire)
11:33AM	Edwards Lifesciences Corporation (NYSE:EW) Q3 2023 Earnings Call Transcript (Insider Monkey)
11:17AM	Edwards Lifesciences (EW) Q3 Earnings Match Mark, Margins Dip (Zacks)
11:12AM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
10:08AM	CONMED (CNMD) Beats on Q3 Earnings, Ups '23 EPS View (Zacks)
07:23AM	Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E (Zacks)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOBO DONALD E JR	CVP,Strategy/Corp Development	May 10 '24	Option Exercise	45.28	5,000	226,384	52,750	May 13 05:45 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	May 10 '24	Sale	87.81	5,000	439,038	47,750	May 13 05:45 PM
Lippis Daniel J.	CVP, JAPAC	May 07 '24	Option Exercise	36.75	857	31,495	25,333	May 09 07:40 PM
Lippis Daniel J.	CVP, JAPAC	May 07 '24	Sale	85.60	857	73,359	23,890	May 09 07:40 PM
Zovighian Bernard J	CEO	May 06 '24	Buy	85.74	580	49,753	3,268	May 07 05:53 PM
Chopra Daveen	CVP, TMTT	May 04 '24	Option Exercise	0.00	4,713	0	27,172	May 06 07:17 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	May 04 '24	Option Exercise	0.00	5,855	0	45,144	May 06 07:16 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 04 '24	Option Exercise	0.00	7,465	0	25,905	May 06 07:18 PM
Szyman Catherine M.	CVP, Critical Care	May 04 '24	Option Exercise	0.00	5,796	0	49,018	May 06 07:18 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	May 04 '24	Option Exercise	0.00	4,157	0	177,969	May 06 07:18 PM
Wood Larry L	Global President TAVR & Surg	May 04 '24	Option Exercise	0.00	6,675	0	220,022	May 06 07:17 PM
Zovighian Bernard J	CEO	May 04 '24	Option Exercise	0.00	6,265	0	50,554	May 07 05:53 PM
MUSSALLEM MICHAEL A	Director	May 02 '24	Option Exercise	36.75	29,350	1,078,612	33,836	May 02 06:05 PM
MUSSALLEM MICHAEL A	Director	May 02 '24	Sale	84.77	29,350	2,487,966	4,486	May 02 06:05 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	May 01 '24	Option Exercise	36.75	14,400	529,200	188,249	May 01 05:17 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	May 01 '24	Sale	84.21	14,400	1,212,687	173,849	May 01 05:17 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 30 '24	Option Exercise	36.75	7,250	266,438	26,324	Apr 30 04:56 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 30 '24	Sale	85.80	7,250	622,062	19,074	Apr 30 04:56 PM
Lippis Daniel J.	CVP, JAPAC	Apr 09 '24	Option Exercise	36.75	857	31,495	18,345	Apr 09 05:33 PM
Lippis Daniel J.	CVP, JAPAC	Apr 09 '24	Sale	92.34	857	79,135	17,488	Apr 09 05:33 PM
Lemercier Jean-Luc M	CVP, EMEACLA	Apr 08 '24	Option Exercise	36.75	14,400	529,200	188,249	Apr 08 05:10 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 08 '24	Option Exercise	36.75	12,500	459,375	52,268	Apr 08 05:10 PM
Lemercier Jean-Luc M	CVP, EMEACLA	Apr 08 '24	Sale	92.32	14,400	1,329,472	173,849	Apr 08 05:10 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 08 '24	Sale	92.33	12,500	1,154,142	39,768	Apr 08 05:10 PM
MUSSALLEM MICHAEL A	Director	Apr 04 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Apr 04 06:26 PM
MUSSALLEM MICHAEL A	Director	Apr 04 '24	Sale	92.42	29,350	2,712,418	4,486	Apr 04 06:26 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 01 '24	Option Exercise	36.75	7,255	266,621	26,329	Apr 01 06:55 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 01 '24	Sale	94.89	7,255	688,423	19,074	Apr 01 06:55 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '24	Option Exercise	36.75	14,500	532,875	54,003	Mar 13 05:44 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '24	Sale	91.01	14,500	1,319,696	39,503	Mar 13 05:44 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	Mar 11 '24	Option Exercise	36.75	14,400	529,200	187,984	Mar 11 06:00 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	Mar 11 '24	Sale	91.68	14,400	1,320,149	173,584	Mar 11 06:00 PM
Lippis Daniel J.	CVP, JAPAC	Mar 07 '24	Option Exercise	36.75	1,715	63,026	18,928	Mar 07 06:22 PM
Lippis Daniel J.	CVP, JAPAC	Mar 07 '24	Sale	90.98	1,715	156,031	17,213	Mar 07 06:22 PM
MUSSALLEM MICHAEL A	Director	Mar 04 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Mar 04 07:16 PM
MUSSALLEM MICHAEL A	Director	Mar 04 '24	Sale	86.67	29,350	2,543,737	4,486	Mar 04 07:16 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 29 '24	Option Exercise	36.75	7,255	266,621	26,329	Feb 29 05:12 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 29 '24	Sale	85.59	7,255	620,923	19,074	Feb 29 05:12 PM
GALLAHUE KIERAN	Director	Feb 23 '24	Option Exercise	36.86	7,056	260,107	10,757	Feb 26 05:52 PM
GALLAHUE KIERAN	Director	Feb 23 '24	Sale	87.61	3,058	267,911	67,219	Feb 26 05:52 PM
Chopra Daveen	CVP, TMTT	Feb 21 '24	Option Exercise	59.26	7,000	414,797	30,950	Feb 21 05:52 PM
Chopra Daveen	CVP, TMTT	Feb 21 '24	Sale	86.74	8,200	711,272	22,750	Feb 21 05:52 PM
Szyman Catherine M.	CVP, Critical Care	Feb 15 '24	Option Exercise	36.75	27,000	992,250	61,814	Feb 15 05:25 PM
Szyman Catherine M.	CVP, Critical Care	Feb 15 '24	Sale	85.62	27,000	2,311,654	34,814	Feb 15 05:25 PM
Szyman Catherine M.	CVP, Critical Care	Feb 13 '24	Option Exercise	36.75	20,000	735,000	54,814	Feb 15 05:25 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '24	Option Exercise	36.75	11,000	404,250	50,503	Feb 13 04:51 PM
Szyman Catherine M.	CVP, Critical Care	Feb 13 '24	Sale	86.46	20,000	1,729,200	34,814	Feb 15 05:25 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '24	Sale	85.83	11,000	944,155	39,503	Feb 13 04:51 PM
SELLERS ROBERT W.A.	SVP, Corporate Controller	Feb 12 '24	Option Exercise	36.75	12,210	448,718	25,297	Feb 12 05:44 PM
SELLERS ROBERT W.A.	SVP, Corporate Controller	Feb 12 '24	Sale	87.00	12,210	1,062,270	13,087	Feb 12 05:44 PM
STONE HEISZ LESLIE	Director	Feb 08 '24	Option Exercise	36.86	7,056	260,107	34,036	Feb 08 06:08 PM
STONE HEISZ LESLIE	Director	Feb 08 '24	Sale	86.45	7,056	609,991	26,980	Feb 08 06:08 PM
MUSSALLEM MICHAEL A	Director	Feb 05 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Feb 05 06:37 PM
MUSSALLEM MICHAEL A	Director	Feb 05 '24	Sale	87.49	29,350	2,567,754	4,486	Feb 05 06:37 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 01 '24	Option Exercise	36.75	7,255	266,621	26,503	Feb 01 05:52 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 01 '24	Sale	78.29	7,255	567,994	19,248	Feb 01 05:52 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 12 '24	Option Exercise	36.75	10,000	367,500	49,503	Jan 12 05:36 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 12 '24	Sale	75.67	10,000	756,700	39,503	Jan 12 05:36 PM
MUSSALLEM MICHAEL A	Director	Jan 05 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Jan 05 07:19 PM
MUSSALLEM MICHAEL A	Director	Jan 05 '24	Sale	72.98	29,350	2,142,089	4,486	Jan 05 07:19 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 29 '23	Option Exercise	36.75	14,510	533,242	33,758	Dec 29 04:25 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 29 '23	Sale	76.55	14,510	1,110,794	19,248	Dec 29 04:25 PM
Chopra Daveen	CVP, TMTT	Dec 15 '23	Option Exercise	59.26	7,000	414,797	30,950	Dec 15 05:22 PM
Chopra Daveen	CVP, TMTT	Dec 15 '23	Sale	78.25	7,000	547,724	23,950	Dec 15 05:22 PM
MUSSALLEM MICHAEL A	Director	Dec 13 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Dec 13 07:04 PM
Wood Larry L	Global President TAVR & Surg	Dec 13 '23	Option Exercise	45.28	8,658	392,006	222,452	Dec 13 07:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 13 '23	Option Exercise	36.75	8,000	294,000	47,503	Dec 13 07:04 PM
MUSSALLEM MICHAEL A	Director	Dec 13 '23	Sale	74.62	29,350	2,190,043	4,486	Dec 13 07:04 PM
Wood Larry L	Global President TAVR & Surg	Dec 13 '23	Sale	71.86	8,658	622,164	213,794	Dec 13 07:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 13 '23	Sale	71.86	8,000	574,880	39,503	Dec 13 07:04 PM
Chopra Daveen	CVP, TMTT	Dec 06 '23	Option Exercise	59.26	3,500	207,398	27,450	Dec 06 05:01 PM
Chopra Daveen	CVP, TMTT	Dec 06 '23	Sale	70.00	3,500	245,006	23,950	Dec 06 05:01 PM
Wood Larry L	Global President TAVR & Surg	Nov 13 '23	Option Exercise	45.28	8,660	392,096	222,454	Nov 13 05:21 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '23	Option Exercise	36.75	6,000	220,500	45,503	Nov 13 05:21 PM
Wood Larry L	Global President TAVR & Surg	Nov 13 '23	Sale	65.30	8,660	565,460	213,794	Nov 13 05:21 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '23	Sale	65.30	6,000	391,780	39,503	Nov 13 05:21 PM
MUSSALLEM MICHAEL A	Director	Nov 03 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Nov 06 06:33 PM
MUSSALLEM MICHAEL A	Director	Nov 03 '23	Sale	67.18	29,350	1,971,733	4,486	Nov 06 06:33 PM
Ullem Scott B.	CVP, Chief Financial Officer	Oct 31 '23	Option Exercise	36.75	7,255	266,621	26,503	Oct 31 05:22 PM
Ullem Scott B.	CVP, Chief Financial Officer	Oct 31 '23	Sale	62.66	7,255	454,569	19,248	Oct 31 05:22 PM
Wood Larry L	Global President TAVR & Surg	Oct 13 '23	Option Exercise	45.28	8,660	392,096	222,454	Oct 13 05:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Oct 13 '23	Option Exercise	36.75	5,000	183,750	44,503	Oct 13 05:01 PM
Wood Larry L	Global President TAVR & Surg	Oct 13 '23	Sale	70.00	8,660	606,198	213,794	Oct 13 05:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Oct 13 '23	Sale	69.98	5,000	349,909	39,503	Oct 13 05:01 PM
Szyman Catherine M.	CVP, Critical Care	Oct 10 '23	Option Exercise	36.75	5,000	183,750	39,814	Oct 10 06:23 PM
Szyman Catherine M.	CVP, Critical Care	Oct 10 '23	Sale	72.68	5,000	363,400	34,814	Oct 10 06:23 PM
Chopra Daveen	CVP, TMTT	Oct 03 '23	Option Exercise	59.26	8,500	503,682	32,450	Oct 03 04:58 PM
Chopra Daveen	CVP, TMTT	Oct 03 '23	Sale	70.00	8,500	595,000	23,950	Oct 03 04:58 PM
MUSSALLEM MICHAEL A	Director	Oct 02 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Oct 02 06:51 PM
MUSSALLEM MICHAEL A	Director	Oct 02 '23	Sale	68.84	29,350	2,020,454	4,486	Oct 02 06:51 PM
Ullem Scott B.	CVP, Chief Financial Officer	Sep 29 '23	Option Exercise	36.75	7,255	266,621	26,503	Sep 29 04:49 PM
Ullem Scott B.	CVP, Chief Financial Officer	Sep 29 '23	Sale	69.54	7,255	504,527	19,248	Sep 29 04:49 PM
Wood Larry L	Global President TAVR & Surg	Sep 14 '23	Option Exercise	45.28	8,660	392,096	222,454	Sep 14 08:00 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Sep 14 '23	Option Exercise	36.75	4,500	165,375	44,003	Sep 14 08:00 PM
Wood Larry L	Global President TAVR & Surg	Sep 14 '23	Sale	73.63	8,660	637,615	213,794	Sep 14 08:00 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Sep 14 '23	Sale	73.71	4,500	331,695	39,503	Sep 14 08:00 PM
Szyman Catherine M.	CVP, Critical Care	Sep 08 '23	Option Exercise	36.75	5,000	183,750	39,814	Sep 08 05:29 PM
Szyman Catherine M.	CVP, Critical Care	Sep 08 '23	Sale	76.00	5,000	380,000	34,814	Sep 08 05:29 PM
Chopra Daveen	CVP, TMTT	Sep 06 '23	Option Exercise	59.26	8,500	503,682	32,450	Sep 06 05:09 PM
Chopra Daveen	CVP, TMTT	Sep 06 '23	Sale	76.07	8,500	646,609	23,950	Sep 06 05:09 PM

Open in Screener

BERY

Berry Global Group Inc

May 17 • 04:00PM ET

60.68

Dollar change -0.02
Percentage change -0.03	%

Consumer Cyclical • Packaging & Containers • USA • NYSE

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: IJH VTI VB COWZ VBR VXF IJJ VYM FXR IWR

Index	-	P/E	14.42	EPS (ttm)	4.21	Insider Own	0.33%	Shs Outstand	115.50M	Perf Week	1.32%
Market Cap	6.94B	Forward P/E	7.39	EPS next Y	8.21	Insider Trans	-36.46%	Shs Float	114.02M	Perf Month	7.74%
Income	504.00M	PEG	1.52	EPS next Q	2.06	Inst Own	100.20%	Short Float	3.57%	Perf Quarter	3.90%
Sales	12.24B	P/S	0.57	EPS this Y	0.87%	Inst Trans	-3.64%	Short Ratio	3.65	Perf Half Y	-0.91%
Book/sh	28.67	P/B	2.12	EPS next Y	9.74%	ROA	3.09%	Short Interest	4.07M	Perf Year	3.43%
Cash/sh	4.32	P/C	14.05	EPS next 5Y	9.50%	ROE	15.30%	52W Range	53.92 - 69.93	Perf YTD	-9.96%
Dividend Est.	0.87 (1.43%)	P/FCF	8.63	EPS past 5Y	6.18%	ROI	4.03%	52W High	-13.23%	Beta	1.19
Dividend TTM	1.05 (1.73%)	Quick Ratio	1.01	Sales past 5Y	11.00%	Gross Margin	16.21%	52W Low	12.54%	ATR (14)	1.18
Dividend Ex-Date	Jun 03, 2024	Current Ratio	1.74	EPS Y/Y TTM	-25.49%	Oper. Margin	9.04%	RSI (14)	60.89	Volatility	1.73% 1.80%
Employees	44000	Debt/Eq	2.84	Sales Y/Y TTM	-9.26%	Profit Margin	4.12%	Recom	2.15	Target Price	70.67
Option/Short	Yes / Yes	LT Debt/Eq	2.80	EPS Q/Q	-30.91%	Payout	20.20%	Rel Volume	0.88	Prev Close	60.70
Sales Surprise	-2.51%	EPS Surprise	2.28%	Sales Q/Q	-6.45%	Earnings	May 09 BMO	Avg Volume	1.12M	Price	60.68
SMA20	3.58%	SMA50	3.08%	SMA200	-1.29%	Trades		Volume	987,646	Change	-0.03%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-16-24	Downgrade	Robert W. Baird	Outperform → Neutral	$68 → $65
Mar-27-24	Downgrade	Truist	Buy → Hold	$75 → $68
Mar-15-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$72 → $62
Mar-01-24	Initiated	Wolfe Research	Peer Perform
Jan-16-24	Resumed	UBS	Buy	$89
Oct-20-23	Resumed	Raymond James	Mkt Perform
May-24-23	Upgrade	Truist	Hold → Buy	$69 → $73
Jan-05-23	Downgrade	Truist	Buy → Hold	$70
Jul-20-22	Upgrade	Credit Suisse	Neutral → Outperform	$78
Jan-28-22	Resumed	Credit Suisse	Neutral
Nov-24-21	Initiated	Raymond James	Mkt Perform
Oct-13-21	Initiated	Mizuho	Neutral	$70
Sep-14-21	Initiated	Truist	Buy	$85
Apr-09-21	Initiated	Goldman	Buy	$75
Oct-14-20	Initiated	Seaport Global Securities	Buy	$71
Sep-17-20	Initiated	UBS	Buy	$70
Jul-13-20	Resumed	Jefferies	Buy	$57
Feb-13-20	Initiated	Credit Suisse	Outperform	$62
Sep-25-19	Upgrade	BofA/Merrill	Neutral → Buy	$51
Aug-22-19	Resumed	Goldman	Buy	$52

Show Previous Ratings

May-15-24 05:07PM	Berry Global Group Insider Sold Shares Worth $5,105,724, According to a Recent SEC Filing (MT Newswires)
May-14-24 10:21AM	Do Options Traders Know Something About Berry Global (BERY) Stock We Don't? (Zacks)
09:16AM	Berry Global (BERY) Prices Senior Notes in Private Offering (Zacks)
May-13-24 08:21PM	Berry Global Announces Pricing of Offering of First Priority Senior Secured Notes (Business Wire)
10:45AM	Deciphering Berry Global (BERY) International Revenue Trends (Zacks)
10:18AM	Loading…
10:18AM	Berry Global Group Unit Starts Tender Offer for Certain Notes, Plans to Issue New Series of Notes (MT Newswires)
09:24AM	Berry Global Announces Tender Offer for Certain Outstanding 4.875% First Priority Senior Secured Notes Due 2026 (Business Wire)
09:17AM	Berry Global Group, Inc. Announces Proposed Offering of First Priority Senior Secured Notes (Business Wire)
May-10-24 12:32PM	Berry Global Group Inc (BERY) Q2 2024 Earnings: Adjusted EPS Slightly Outperforms Analyst ... (GuruFocus.com)
11:59AM	Berry Global Group, Inc. (NYSE:BERY) Q2 2024 Earnings Call Transcript (Insider Monkey)
11:29AM	Berry Global (BERY) Q2 Earnings Beat Estimates, Revenues Miss (Zacks)
06:34AM	Q1 2024 Glatfelter Corp Earnings Call (Thomson Reuters StreetEvents)
05:01AM	Berry Global reports 6% sales decline in Q2 FY24 (Packaging Gateway)
12:25AM	Q2 2024 Berry Global Group Inc Earnings Call (Thomson Reuters StreetEvents)
May-09-24 09:30AM	Here's What Key Metrics Tell Us About Berry Global (BERY) Q2 Earnings (Zacks)
08:43AM	Loading…
08:43AM	Berry Global Group Q2 Profit Declines (RTT News)
08:20AM	Berry Global (BERY) Tops Q2 Earnings Estimates (Zacks)
07:51AM	Berry Global Group's Fiscal Q2 Adjusted Earnings, Net Sales Decline (MT Newswires)
07:19AM	Berry Global: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Berry Announces Second Quarter 2024 Results (Business Wire)
May-07-24 05:00PM	Berry Declares Quarterly Dividend (Business Wire)
May-06-24 09:16AM	Unveiling Berry Global (BERY) Q2 Outlook: Wall Street Estimates for Key Metrics (Zacks)
May-02-24 10:01AM	Earnings Preview: Berry Global (BERY) Q2 Earnings Expected to Decline (Zacks)
Apr-30-24 08:30AM	Democrats and Corporate Insiders are Buying These 10 Stocks (Insider Monkey)
Apr-29-24 06:42AM	Berry and Peel Plastics win award for sustainable pet food packaging (Packaging Gateway)
Apr-25-24 03:24AM	What Makes Berry Global Group (BERY) a Boring Company as per Blue Tower Asset Management? (Insider Monkey)
Apr-24-24 04:03PM	Citi Eyes $2 Billion Debt Package for Berry, Glatfelter Deal (Bloomberg)
Apr-17-24 09:15AM	NewHold Enterprises Announces Sale of F&S Tool to Berry Global (PR Newswire)
07:15AM	Berry and Glatfelter Announce Regulatory Milestone in Proposed Transaction for Spin-Off and Merger of Berrys Health, Hygiene and Specialties Global Nonwovens and Films Business with Glatfelter (Business Wire)
Apr-11-24 05:30PM	Berry Global Group, Inc. to Release Second Fiscal Quarter 2024 Results on May 9, 2024 (Business Wire)
06:50AM	Loading…
06:50AM	Glatfelter Announces Key Leadership Appointments in Connection With Proposed Merger With Berry's Health, Hygiene, and Specialties Global Nonwovens and Films Business (GlobeNewswire)
Apr-10-24 03:56PM	16 Best Materials Stocks To Buy in 2024 (Insider Monkey)
Apr-09-24 10:48AM	12 Best Packaging Stocks to Buy According to Hedge Funds (Insider Monkey)
10:14AM	2023 Sustainability Report Shows How Berry Global is Delivering on its Impact 2025 Strategy (Business Wire)
Feb-24-24 07:06AM	Director Robert Steele Sells 14,000 Shares of Berry Global Group Inc (GuruFocus.com)
Feb-13-24 09:45AM	Berry Global Unveils New Circular Stretch Film Innovation and Training Center in Tulsa, Oklahoma (Business Wire)
Feb-09-24 05:02PM	Director Peter Thomas Acquires 2,000 Shares of Berry Global Group Inc (GuruFocus.com) +5.54%
Feb-08-24 10:29AM	Berry Global Group, Inc. (NYSE:BERY) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:51AM	Berry Global (BERY) Q1 Earnings & Revenues Miss Estimates (Zacks)
01:05AM	Q1 2024 Berry Global Group Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-07-24 05:50PM	Why Berry Global Stock Plunged Today (Motley Fool) -11.78%
09:30AM	Compared to Estimates, Berry Global (BERY) Q1 Earnings: A Look at Key Metrics (Zacks)
08:35AM	Berry Global (BERY) Lags Q1 Earnings and Revenue Estimates (Zacks)
07:36AM	Berry Global Group Inc (BERY) Posts Mixed Q1 2024 Results Amid Market Challenges (GuruFocus.com)
07:33AM	Berry Global: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:15AM	Berry Announces First Quarter 2024 Results (Business Wire)
07:00AM	Berry Global and Glatfelter Announce Plans for Tax-Free Spin-Off and Merger of Berrys Health, Hygiene and Specialties Global Nonwovens and Films Business with Glatfelter, Creating a Global Specialty Materials Leader (Business Wire)
Feb-05-24 09:16AM	Gear Up for Berry Global (BERY) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Feb-01-24 05:30PM	Berry Declares Quarterly Dividend (Business Wire)
Jan-31-24 10:00AM	Earnings Preview: Berry Global (BERY) Q1 Earnings Expected to Decline (Zacks)
Jan-29-24 05:30PM	Berry Global Group, Inc. Announces Notes Exchange Offers (Business Wire)
Jan-22-24 08:19AM	These 3 Packaging Stocks Are Ready to Deliver Profits, Says UBS (TipRanks)
Jan-16-24 10:32AM	Here's Why You Should Avoid Investing in Berry Global (BERY) (Zacks)
Jan-11-24 05:30PM	Berry Global Group, Inc. to Release First Fiscal Quarter 2024 Results on February 7, 2024 (Business Wire)
08:15AM	Berry Global (BERY) Prices $800M Senior Notes in Private Offering (Zacks)
Jan-10-24 04:47PM	Berry Global Announces Pricing of Offering of First Priority Senior Secured Notes (Business Wire)
08:46AM	Berry Global Group, Inc. Announces Proposed Offering of First Priority Senior Secured Notes (Business Wire)
Dec-07-23 03:05PM	Insider Sell: CFO Mark Miles Sells 40,000 Shares of Berry Global Group Inc (BERY) (GuruFocus.com)
Dec-01-23 11:04PM	Insider Sell Alert: Director Carl Rickertsen Sells 18,951 Shares of Berry Global Group Inc (GuruFocus.com)
Nov-28-23 09:39AM	Berry Global (BERY) Gains 12.9% in a Year: Will the Trend Last? (Zacks)
Nov-23-23 05:04AM	Insider Sell: Chief Legal Officer Jason Greene Sells Shares of Berry Global Group Inc (GuruFocus.com)
Nov-20-23 09:32AM	Berry Global Group, Inc. (NYSE:BERY) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:57AM	Berry Global (BERY) Rewards Shareholders With 10% Dividend Hike (Zacks)
Nov-17-23 12:09PM	Berry Global (BERY) Q4 Earnings Beat Estimates, Revenues Miss (Zacks)
03:43AM	Q4 2023 Berry Global Group Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-16-23 09:30AM	Berry Global (BERY) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
09:26AM	Berry Global Group Inc (BERY) Reports Decline in Net Sales and Operating Income for Fiscal Year 2023 (GuruFocus.com)
07:18AM	Berry Global: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Berry Announces Strong Fourth Quarter and Fiscal Year 2023 Results (Business Wire)
06:45AM	Berry Announces Quarterly Dividend Increase of 10% (Business Wire)
Nov-14-23 11:11AM	What's in the Offing for Berry Global (BERY) in Q4 Earnings? (Zacks) +5.36%
08:00AM	Berry Global Named to 100 Best Corporate Citizens of 2023 for Strong ESG Performance (Business Wire)
Nov-13-23 11:49AM	Stay Ahead of the Game With Berry Global (BERY) Q4 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Nov-09-23 10:00AM	Earnings Preview: Berry Global (BERY) Q4 Earnings Expected to Decline (Zacks)
Oct-27-23 10:51PM	Director Evan Bayh Sells 14,000 Shares of Berry Global Group Inc (GuruFocus.com)
Oct-20-23 12:45PM	Ozempic is Crushing Cardboard and Cans (The Wall Street Journal)
Oct-19-23 04:30PM	Berry Global Group, Inc. to Release Fourth Quarter and Fiscal Year 2023 Results on November 16, 2023 (Business Wire)
Oct-14-23 06:21AM	Top 15 Bioplastics Companies in the World (Insider Monkey)
Sep-22-23 11:31AM	Berry Global (BERY) to Advance Sustainability in Mexico (Zacks)
Sep-20-23 09:00AM	Berry Global Partners with ACCIONA Energía to Power its Mexico Operations with 100% Renewable Electricity (Business Wire)
Sep-15-23 11:30AM	Amcor (AMCR) Down 0.4% Since Last Earnings Report: Can It Rebound? (Zacks)
Sep-13-23 09:47PM	The 7 Most Undervalued Safe Stocks to Buy in September 2023 (InvestorPlace)
Sep-12-23 09:00AM	Berry Upgraded to "A" Rating from MSCI for Effective ESG Management (Business Wire)
Sep-08-23 11:30AM	Berry Global (BERY) Down 8.3% Since Last Earnings Report: Can It Rebound? (Zacks)
08:24AM	UPDATE 2-Berry Global launches review of health, hygiene and specialties segment (Reuters)
08:12AM	Berry Global initiates formal review to evaluate alternatives for health segment (Reuters)
08:00AM	Berry Global Announces Review of Strategic Alternatives for its Health, Hygiene and Specialties Segment (Business Wire)
Aug-29-23 12:24PM	Berry Global (BERY) Gains 15.8% in a Year: Will the Trend Last? (Zacks)
Aug-21-23 01:03PM	What's in the Offing for Donaldson (DCI) in Q4 Earnings? (Zacks)
Aug-16-23 01:29PM	Berry Global (BERY) Picks Kwilinski to Replace Salmon as CEO (Zacks)
Aug-15-23 09:00AM	Berry Global Appoints Kevin Kwilinski as Chief Executive Officer (Business Wire)
Aug-10-23 04:04PM	Berry Global Group Inc: A High-Performing Stock with Strong Growth and Profitability (GuruFocus.com) +5.30%
11:14AM	Berry Global (BERY) Q3 Earnings & Revenues Miss, Decline Y/Y (Zacks)
01:11AM	Q3 2023 Berry Global Group Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-09-23 04:02PM	Berry Global Group Inc: A High-Performing Contender in the Packaging & Containers Industry (GuruFocus.com)
09:30AM	Berry Global (BERY) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:50AM	Berry Global (BERY) Misses Q3 Earnings and Revenue Estimates (Zacks)
07:46AM	Berry Global: Fiscal Q3 Earnings Snapshot (AP Finance)
07:00AM	Berry Announces Third Quarter 2023 Results (Business Wire)
Aug-08-23 08:15AM	Sealed Air (SEE) Surpasses Q2 Earnings Estimates (Zacks)

Berry Global Group, Inc. engages in the provision of non-woven products. It operates through the following segments: Consumer Packaging International, Consumer Packaging North America, Engineered Materials, and Health, Hygiene and Specialties. The Consumer Packaging International segment consists of products that primarily service non-North American markets. The Engineered Materials segment involves the manufacture of flexible products that service primarily North American and European markets. The Health, Hygiene and Specialties segment refers to services to global markets. The company was founded in 1967 and is headquartered in Evansville, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Miles Mark W	Chief Financial Officer	May 15 '24	Option Exercise	28.75	1,548	44,505	120,502	May 15 05:04 PM
Miles Mark W	Chief Financial Officer	May 15 '24	Sale	60.29	1,118	67,404	119,384	May 15 05:04 PM
Miles Mark W	Chief Financial Officer	May 14 '24	Option Exercise	28.75	118,452	3,405,495	202,954	May 15 05:04 PM
Miles Mark W	Chief Financial Officer	May 14 '24	Sale	59.98	84,000	5,038,320	118,954	May 15 05:04 PM
FOSTER JONATHAN F	Director	May 02 '24	Option Exercise	22.95	14,000	321,300	19,728	May 06 02:42 PM
Steele Robert Allan	Director	Feb 24 '24	Sale	58.93	14,000	825,020	4,728	Feb 23 04:34 PM
Steele Robert Allan	Director	Feb 21 '24	Option Exercise	28.75	14,000	402,500	18,728	Feb 23 04:34 PM
FOSTER JONATHAN F	Director	Feb 12 '24	Buy	58.49	1,000	58,490	5,728	Feb 13 01:58 PM
Kwilinski Kevin J.	Chief Executive Officer	Feb 09 '24	Buy	57.44	2,000	114,880	2,000	Feb 09 02:52 PM
Bayh Evan	Director	Feb 09 '24	Buy	57.83	1,000	57,830	30,228	Feb 09 02:56 PM
Thomas Peter T	Director	Feb 08 '24	Buy	56.00	2,000	112,000	2,000	Feb 09 03:03 PM
Till James	Controller	Dec 05 '23	Option Exercise	29.59	11,903	352,210	11,903	Dec 06 04:36 PM
Till James	Controller	Dec 05 '23	Sale	65.32	11,903	777,504	0	Dec 06 04:36 PM
Miles Mark W	Chief Financial Officer	Dec 04 '23	Option Exercise	28.75	40,000	1,150,000	124,502	Dec 06 04:40 PM
Till James	Controller	Dec 04 '23	Option Exercise	29.59	20,097	594,670	20,097	Dec 06 04:36 PM
Miles Mark W	Chief Financial Officer	Dec 04 '23	Sale	66.29	40,000	2,651,600	84,502	Dec 06 04:40 PM
Till James	Controller	Dec 04 '23	Sale	66.81	20,097	1,342,681	0	Dec 06 04:36 PM
RICKERTSEN CARL J	Director	Nov 29 '23	Option Exercise	47.29	18,951	896,205	14,258	Dec 01 04:58 PM
RICKERTSEN CARL J	Director	Nov 29 '23	Sale	64.96	18,951	1,231,057	2,758	Dec 01 04:58 PM
RICKERTSEN CARL J	Director	Nov 24 '23	Option Exercise	49.56	7,849	388,964	10,058	Nov 28 04:50 PM
RICKERTSEN CARL J	Director	Nov 24 '23	Sale	64.81	7,849	508,694	2,758	Nov 28 04:50 PM
Greene Jason K.	Chief Legal Officer	Nov 21 '23	Option Exercise	28.75	24,480	703,800	24,730	Nov 22 05:00 PM
RICKERTSEN CARL J	Director	Nov 21 '23	Option Exercise	49.53	200	9,906	200	Nov 22 04:50 PM
Greene Jason K.	Chief Legal Officer	Nov 21 '23	Sale	64.62	24,480	1,581,898	250	Nov 22 05:00 PM
RICKERTSEN CARL J	Director	Nov 21 '23	Sale	65.00	200	13,000	0	Nov 22 04:50 PM
Bayh Evan	Director	Oct 27 '23	Option Exercise	21.00	14,000	294,000	41,258	Oct 27 05:19 PM
Bayh Evan	Director	Oct 27 '23	Sale	54.57	14,000	763,980	27,258	Oct 27 05:19 PM
Miles Mark W	Chief Financial Officer	Aug 15 '23	Option Exercise	21.00	50,000	1,050,000	115,456	Aug 17 04:46 PM
Miles Mark W	Chief Financial Officer	Aug 15 '23	Sale	65.76	30,954	2,035,535	84,502	Aug 17 04:46 PM
Norman William J	President	Aug 11 '23	Option Exercise	28.75	9,000	258,750	9,000	Aug 14 04:52 PM
Norman William J	President	Aug 11 '23	Sale	66.48	9,000	598,320	0	Aug 14 04:52 PM
Norman William J	President	Aug 10 '23	Option Exercise	28.75	30,000	862,500	30,000	Aug 14 04:52 PM
Norman William J	President	Aug 10 '23	Sale	66.11	30,000	1,983,300	0	Aug 14 04:52 PM
Greene Jason K.	Chief Legal Officer	Jul 25 '23	Option Exercise	28.75	520	14,950	770	Jul 26 05:11 PM
Greene Jason K.	Chief Legal Officer	Jul 25 '23	Sale	68.01	520	35,365	250	Jul 26 05:11 PM
Hill Michael Edward	President	Jul 18 '23	Option Exercise	29.59	28,369	839,439	28,369	Jul 19 05:06 PM
Hill Michael Edward	President	Jul 18 '23	Sale	66.57	28,369	1,888,524	0	Jul 19 05:06 PM
Hill Michael Edward	President	Jul 12 '23	Option Exercise	29.59	4	107	3,631	Jul 13 05:06 PM
Hill Michael Edward	President	Jul 12 '23	Sale	66.52	3,631	241,534	0	Jul 13 05:06 PM
Hill Michael Edward	President	Jun 16 '23	Option Exercise	25.36	24,910	631,610	14,000	Jun 20 05:23 PM
Hill Michael Edward	President	Jun 16 '23	Sale	64.13	24,910	1,597,478	0	Jun 20 05:23 PM
Hill Michael Edward	President	Jun 14 '23	Option Exercise	21.00	1,090	22,890	1,090	Jun 15 05:04 PM
Hill Michael Edward	President	Jun 14 '23	Sale	63.51	1,090	69,226	0	Jun 15 05:04 PM
Miles Mark W	Chief Financial Officer	Jun 06 '23	Option Exercise	21.00	50,000	1,050,000	97,058	Jun 07 05:25 PM
Miles Mark W	Chief Financial Officer	Jun 06 '23	Sale	61.34	31,602	1,938,467	65,456	Jun 07 05:25 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

ILMN

Illumina Inc

EW

Edwards Lifesciences Corp

BERY

Berry Global Group Inc

Upgrade your FINVIZ experience